Skip to main content

Cavers Greg's Form 4 filing

Helus Pharma Inc.HELP · filed Oct 1, 2026

Accession no.
0000912282-26-001334
Filed
Oct 1, 2026, 8:13 PM ET
Trade date
Sep 29, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market purchases total $38.7K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cavers GregCIK 0002116548Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 29, 2026Common SharesPPurchaseAcquired+3,000$12.91F1+$38,7303,000Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Converted from Canadian purchase price of C$18.3157 using an exchange rate of C$1.4188 = US$1.00.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)